These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31480886)

  • 21. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support.
    Wieruszewski PM; Seelhammer TG; Barreto EF; Busse LW; Chow JH; Davison DL; Gaglani B; Khanna AK; Ten Lohuis CC; Mara KC; Wittwer ED
    J Intensive Care Med; 2023 May; 38(5):464-471. PubMed ID: 36524274
    [No Abstract]   [Full Text] [Related]  

  • 23. Angiotensin II Brings More Questions Than Answers.
    Farina N; Bixby A; Alaniz C
    P T; 2018 Nov; 43(11):685-687. PubMed ID: 30410284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II for the Treatment of Vasodilatory Shock.
    Khanna A; English SW; Wang XS; Ham K; Tumlin J; Szerlip H; Busse LW; Altaweel L; Albertson TE; Mackey C; McCurdy MT; Boldt DW; Chock S; Young PJ; Krell K; Wunderink RG; Ostermann M; Murugan R; Gong MN; Panwar R; Hästbacka J; Favory R; Venkatesh B; Thompson BT; Bellomo R; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Deane AM;
    N Engl J Med; 2017 Aug; 377(5):419-430. PubMed ID: 28528561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II - A Brief Review and Role in Severe SARS-COV-2 Sepsis.
    Carà GA; Pasin L; Alborino E; Zarbock A; Bellomo R; Landoni G
    J Cardiothorac Vasc Anesth; 2022 Dec; 36(12):4496-4500. PubMed ID: 35995637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis.
    Smith LM; Mentz GB; Engoren MC
    Crit Care Med; 2023 Dec; 51(12):1674-1684. PubMed ID: 37378469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II Use in Refractory Multisystem Shock: A Case Report.
    Ahmed M; Habis S; Mahmoud A; Rutland C; Saeed R
    Cureus; 2018 Nov; 10(11):e3665. PubMed ID: 30740284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II in Refractory Septic Shock.
    Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
    Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjunctive vasopressors in distributive shock: How soon is early?
    Garcia B; Legrand M
    Crit Care; 2023 May; 27(1):210. PubMed ID: 37254175
    [No Abstract]   [Full Text] [Related]  

  • 30. Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019-Induced Vasodilatory Shock: A Retrospective Matched Cohort Study.
    Leisman DE; Mastroianni F; Fisler G; Shah S; Hasan Z; Narasimhan M; Taylor MD; Deutschman CS
    Crit Care Explor; 2020 Oct; 2(10):e0230. PubMed ID: 33063034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
    Bellomo R; Forni LG; Busse LW; McCurdy MT; Ham KR; Boldt DW; Hästbacka J; Khanna AK; Albertson TE; Tumlin J; Storey K; Handisides D; Tidmarsh GF; Chawla LS; Ostermann M
    Am J Respir Crit Care Med; 2020 Nov; 202(9):1253-1261. PubMed ID: 32609011
    [No Abstract]   [Full Text] [Related]  

  • 33. A Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock.
    Bissell BD; Browder K; McKenzie M; Flannery AH
    Ann Pharmacother; 2018 Sep; 52(9):920-927. PubMed ID: 29582666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THE ROLE OF ANGIOTENSIN -2 IN THE PATHOGENESIS OF SEPTIC SHOCK DURING MULTIORGAN DYSFUNCTION SYNDROME (REVIEW).
    Rurua M; Machavariani K; Sanikidze T; Shoshiashvili V; Pachkoria E; Ratiani L
    Georgian Med News; 2022 Feb; (323):157-161. PubMed ID: 35271489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasodilatory shock in the ICU and the role of angiotensin II.
    Wakefield BJ; Sacha GL; Khanna AK
    Curr Opin Crit Care; 2018 Aug; 24(4):277-285. PubMed ID: 29877879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraoperative Use of Angiotensin II for Severe Vasodilatory Shock During Liver Transplantation: A Case Report.
    Running K; Weinberg D; Trudo W; Sullivan CL; Patel GP
    A A Pract; 2021 Feb; 15(2):e01402. PubMed ID: 33577171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.
    Busse LW; McCurdy MT; Ali O; Hall A; Chen H; Ostermann M
    Crit Care; 2017 Dec; 21(1):324. PubMed ID: 29282149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of angiotensin II as vasopressor in vasodilatory shock.
    Lumlertgul N; Ostermann M
    Future Cardiol; 2020 Nov; 16(6):569-583. PubMed ID: 32462921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.